Emory University;DANA-FARBER CANCER INSTITUTE, INC.
发明人:
Freeman, Gordon J.,Ahmed, Rafi,Jones, Timothy D.,Carr, Francis J.,Gregson, James P.
申请号:
AU2009296392
公开号:
AU2009296392B2
申请日:
2009.09.25
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (